Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Orlando Armignacco; Gloria Taliani; Giovanni Guaraldi; Massimo Puoti; Massimo Galli; Gioacchino Angarano; Paolo Grossi; Adriano Lazzarin; Andrea De Luca; Marco Borderi; Andrea Antinori; Antonella Castagna; Evangelista Sagnelli; Massimo Andreoni; Giampiero Carosi; Raffaele Bruno; Carlo Torti; Antonella d’Arminio Monforte; Paolo Bonfanti; Cristina Mussini; Teresa Santantonio; Antonio Chirianni; Caterina Uberti‐Foppa; Franco Maggiolo; Carlo Federico Perno; Caterina Sagnelli; Stefano Bonora; Giovanni Di Perri; Giovanni Battista Gaeta; Giuliano Rizzardini; Marcello Tavio

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Orlando Armignacco(Ospedale di Belcolle), Gloria Taliani(Sapienza University of Rome), Giovanni Guaraldi(University of Modena and Reggio Emilia), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Massimo Galli(Luigi Sacco Hospital), Gioacchino Angarano(University of Bari Aldo Moro), Paolo Grossi(University of Insubria), Adriano Lazzarin(Vita-Salute San Raffaele University), Andrea De Luca(Agostino Gemelli University Polyclinic), Marco Borderi(Policlinico S.Orsola-Malpighi), Andrea Antinori(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Antonella Castagna(Vita-Salute San Raffaele University), Evangelista Sagnelli(University of Campania "Luigi Vanvitelli"), Massimo Andreoni(University of Rome Tor Vergata), Giampiero Carosi(Institute for Scientific Interchange), Raffaele Bruno(University of Pavia), Carlo Torti(Magna Graecia University), Antonella d’Arminio Monforte(University of Milan), Paolo Bonfanti(University of California San Diego), Cristina Mussini(University of Modena and Reggio Emilia), Teresa Santantonio(Ospedali Riuniti di Foggia), Antonio Chirianni(Université Ouaga II), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Carlo Federico Perno(Centre International De Reference Chantal Biya), Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Stefano Bonora(Ospedale Amedeo di Savoia), Giovanni Di Perri(University of Turin), Giovanni Battista Gaeta, Giuliano Rizzardini(Luigi Sacco Hospital), Marcello Tavio

PubMed

October 1, 2014

Cited by 5

|New England Journal of Medicine|2022|2.2k

Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population

|Clinical Infectious Diseases|2011|1.3k

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

|The Lancet|2003|1.2k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

|The Lancet Rheumatology|2020|998

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Related Papers